Location History:
- Bronx, NY (US) (1998 - 2000)
- Teaneck, NJ (US) (2003 - 2022)
Company Filing History:
Years Active: 1998-2022
Title: Harris Goldstein: Innovator in HIV Research
Introduction
Harris Goldstein is a prominent inventor based in Teaneck, NJ (US), known for his significant contributions to the field of HIV research. With a total of 4 patents, Goldstein has focused on developing innovative methods to combat HIV and improve the clinical outcomes for patients.
Latest Patents
Goldstein's latest patents include groundbreaking work on the precision activation of HIV-specific CTLs to eliminate reactivated latent T cells. This invention encompasses compositions and methods designed to enhance the in vivo capacity of CD8+ T cells to target and kill HIV-infected cells. His research aims to functionally cure HIV infection or improve the clinical course of the disease. Additionally, he has developed a self-contained system for sustained viral replication, which involves transgenic non-human animals that can be used to investigate the factors modulating in vivo replication of human pathogens.
Career Highlights
Harris Goldstein is affiliated with the Albert Einstein College of Medicine, where he continues to advance his research in HIV and related fields. His work has garnered attention for its potential to lead to novel therapies and vaccines that can effectively modify or inhibit the course of pathogenesis.
Collaborations
Goldstein has collaborated with notable colleagues, including Tobias R. Kollmann and Steven Craig Almo, to further enhance the impact of his research in the scientific community.
Conclusion
Harris Goldstein's innovative work in HIV research exemplifies the critical role of inventors in advancing medical science. His patents and ongoing research efforts contribute significantly to the fight against HIV and the development of effective treatments.